Intensive Care Decision-making, Survival and Dying Well
2 other identifiers
observational
50
1 country
1
Brief Summary
The goal of this study is to investigate how the experiences of intensive care patients and their end-of-life wishes affect their willingness to accept intensive care treatment at different chances of survival. The main questions it aims to answer are:
- What can ICU survivors' experiences of ICU treatment tell us about what it would be like to die whilst receiving ICU treatment?
- How do ICU survivors' reflections about what it might be like to die on ICU relate to their own preferences for their end-of-life care?
- What chance of survival would make ICU survivors willing to go through ICU treatment again, in light of the fact that the alternative chance is dying whilst experiencing ICU treatment?
- How does the possibility of reduction in health-related quality of life and functional decline as a result of critical illness impact ICU survivors' willingness to accept ICU treatment again? Participating in this study will involve filling out a questionnaire and then taking part in an interview. Participants will be recruited through ICU review clinics and ICU steps groups. The study will last for two years and will be conducted at locations convenient to the participants or via zoom.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2023
CompletedFirst Posted
Study publicly available on registry
September 7, 2023
CompletedStudy Start
First participant enrolled
October 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 16, 2025
January 1, 2025
2 years
August 9, 2023
January 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The chance of survival that would make participants willing to go through critical care treatment again.
The mixed methods approach will involve triangulation of qualitative and questionnaire data about participants' experiences of intensive care treatment, end-of-life wishes, and the chance of survival that would make them willing to go through critical care treatment again.
2 years
Eligibility Criteria
Adult (over the age of 18) participants who have experience as a patient on an intensive care/critical care unit will be recruited in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manchesterlead
- The Royal College of Anaesthetistscollaborator
Study Sites (1)
University of Manchester
Manchester, M13 9PL, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas M Donaldson, MB/BChir
University of Manchester
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
August 9, 2023
First Posted
September 7, 2023
Study Start
October 2, 2023
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
January 16, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- At the end of the study.
At the end of the project, the investigators will deposit a fully anonymised dataset \[e.g., including de-identified interview transcripts\] in an open data repository where it will be permanently stored. The investigators will use Figshare at the University of Manchester Library. Researchers at other institutions and others can access the anonymised data directly from the repository and use it for further research or to check the analysis and results. Participants are informed of this in the participant information sheet and will be asked to consent to this on the consent form.